Cite
APA Citation
Tarhini, A. A., Moschos, S. J., Lin, Y., Lin, H., Sander, C., Yin, Y., Venhaus, R., Gajewski, T. F., & Kirkwood, J. M. (2017). safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma. Melanoma research, 27(4), . http://access.bl.uk/ark:/81055/vdc_100070746314.0x000025